Preventive effect of agaro-oligosaccharides on non-steroidal anti-inflammatory drug-induced small intestinal injury in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 2, 2014, Pages 310-317

  Higashimura, Yasuki ^a,b   Naito, Yuji ^a   Takagi, Tomohisa ^a   Tanimura, Yuko ^a,b   Mizushima, Katsura ^a   Harusato, Akihito ^a   Fukui, Akifumi ^a   Yoriki, Hiroyuki ^a   Handa, Osamu ^a   Ohnogi, Hiromu ^b,c   Yoshikawa, Toshikazu ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c TAKARA BIO INC   (Japan)

Author keywords

Heme oxygenase; Indomethacin; Interleukin 8; Keratinocyte chemoattractant; M2 macrophage

Indexed keywords

AGAROOLIGOSACCHARIDE DERIVATIVE; ARGINASE 1; CARBOHYDRATE DERIVATIVE; CHEMOATTRACTANT; CHITINASE; CHITINASE 3 LIKE 3; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; INDOMETACIN; KERATINOCYTE CHEMOATTRACTANT; MANNOSE RECEPTOR; MANNOSE RECEPTOR 1; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARGINASE; BETA N ACETYLHEXOSAMINIDASE; CELL SURFACE RECEPTOR; CHEMOTACTIC FACTOR; CHI3L3 PROTEIN, MOUSE; HEME OXYGENASE; INTERLEUKIN 8; LECTIN; MEMBRANE PROTEIN; MRC1 PROTEIN, MOUSE; OLIGOSACCHARIDE; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL TRACT; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE ULCER; MACROPHAGE FUNCTION; MALE; MEDIATOR; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SMALL INTESTINE MUCOSA; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; ENTEROPATHY; ENZYMOLOGY; INTESTINE MUCOSA; KERATINOCYTE; M2 MACROPHAGE; METABOLISM; ORAL DRUG ADMINISTRATION; SMALL INTESTINE;

HEME OXYGENASE; INDOMETHACIN; INTERLEUKIN-8; KERATINOCYTE CHEMOATTRACTANT; M2 MACROPHAGE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARGINASE; BETA-N-ACETYLHEXOSAMINIDASES; CHEMOTACTIC FACTORS; HEME OXYGENASE-1; INDOMETHACIN; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; KERATINOCYTES; LECTINS; MACROPHAGES, PERITONEAL; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; OLIGOSACCHARIDES; PEROXIDASE; RECEPTORS, CELL SURFACE;

EID: 84907290013     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12373     Document Type: Article

References (42)

1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1992; 327: 749-754.
2. Naito Y, Iinuma S, Yagi N etal. Prevention of indomethacin-induced gastric mucosal injury in helicobacter pylori-negative healthy volunteers: a comparison study rebamipide vs famotidine. J. Clin. Biochem. Nutr. 2008; 43: 34-40.
3. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin. Gastroenterol. Hepatol. 2005; 3: 133-141.
4. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000; 405: 417-418.
5. Yamamoto H, Sekine Y, Sato Y etal. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest. Endosc. 2001; 53: 216-220.
6. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178.
7. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317.
8. Takagi T, Naito Y, Uchiyama K, Yoshikawa T. The role of heme oxygenase and carbon monoxide in inflammatory bowel disease. Redox Rep. 2010; 15: 193-201.
9. Ponka P. Cell biology of heme. Am. J. Med. Sci. 1999; 318: 241-256.
10. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 1969; 244: 6388-6394.
11. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 1996; 15: 9-19.
12. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am. J. Respir. Cell Mol. Biol. 2009; 41: 251-260.
13. Naito Y, Takagi T, Uchiyama K, Yoshikawa T. Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. J. Clin. Biochem. Nutr. 2011; 48: 126-133.
14. Zhong W, Xia Z, Hinrichs D etal. Hemin exerts multiple protective mechanisms and attenuates dextran sulfate sodium-induced colitis. J. Pediatr. Gastroenterol. Nutr. 2010; 50: 132-139.
15. Yoriki H, Naito Y, Takagi T etal. Hemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1. J. Gastroenterol. Hepatol. 2013; 28: 632-638.
16. Higashimura Y, Naito Y, Takagi T etal. Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression. J. Gastroenterol. 2013; 48: 897-909.
17. Li X, Schwacha MG, Chaudry IH, Choudhry MA. Heme oxygenase-1 protects against neutrophil-mediated intestinal damage by down-regulation of neutrophil p47phox and p67phox activity and O2- production in a two-hit model of alcohol intoxication and burn injury. J. Immunol. 2008; 180: 6933-6940.
18. Wang WP, Guo X, Koo MW etal. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2001; 281: G586-594.
19. Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment. Pharmacol. Ther. 2004; 20 (Suppl. 1): 177-184.
20. Araki C, Arai K. Studies on the chemical constitution of agar-agar. XXIV. Isolation of a new disaccharide as a reversion product from acidic hydrolysate. Bull. Chem. Soc. Jpn 1967; 40: 1452-1456.
21. Enoki T, Okuda S, Kudo Y, Takashima F, Sagawa H, Kato I. Oligosaccharides from agar inhibit pro-inflammatory mediator release by inducing heme oxygenase 1. Biosci. Biotechnol. Biochem. 2010; 74: 766-770.
22. Chen HM, Yan XJ. Antioxidant activities of agaro-oligosaccharides with different degrees of polymerization in cell-based system. Biochim. Biophys. Acta 2005; 1722: 103-111.
23. Chen H, Yan X, Zhu P, Lin J. Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo. Nutr. J. 2006; 5: 31-42.
24. Enoki T, Tominaga T, Takashima F, Ohnogi H, Sagawa H, Kato I. Anti-tumor-promoting activities of agaro-oligosaccharides on two-stage mouse skin carcinogenesis. Biol. Pharm. Bull. 2012; 35: 1145-1149.
25. Takagi T, Naito Y, Mizushima K etal. Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 2008; 23 (Suppl. 2): S229-233.
26. Harusato A, Naito Y, Takagi T etal. Suppression of indomethacin-induced apoptosis in the small intestine due to Bach1 deficiency. Free Radic. Res. 2011; 45: 717-727.
27. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am. J. Physiol. 1986; 251: G567-574.
28. Klemz R, Mashreghi MF, Spies C, Volk HD, Kotsch K. Amplifying the fluorescence of bilirubin enables the real-time detection of heme oxygenase activity. Free Radic. Biol. Med. 2009; 46: 305-311.
29. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009; 27: 451-483.
30. Harusato A, Naito Y, Takagi T etal. Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice. J. Physiol. Pharmacol. 2009; 60 (Suppl. 7): 149-154.
31. Yeh CT, Chiu HF, Yen GC. Protective effect of sulforaphane on indomethacin-induced cytotoxicity via heme oxygenase-1 expression in human intestinal Int 407 cells. Mol. Nutr. Food Res. 2009; 53: 1166-1176.
32. Higuchi K, Yoda Y, Amagase K etal. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J. Clin. Biochem. Nutr. 2009; 45: 125-130.
33. Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun. 2009; 33: 222-230.
34. MacKinnon AC, Farnworth SL, Hodkinson PS etal. Regulation of alternative macrophage activation by galectin-3. J. Immunol. 2008; 180: 2650-2658.
35. Vats D, Mukundan L, Odegaard JI etal. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006; 4: 13-24.
36. Nelson SM, Lei X, Prabhu KS. Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. J. Nutr. 2011; 141: 1754-1761.
37. Harusato A, Naito Y, Takagi T etal. BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1. Inflamm. Bowel Dis. 2013; 19: 740-753.
38. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997; 37: 517-554.
39. Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, McCurry KR. Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J. Clin. Biochem. Nutr. 2008; 42: 78-88.
40. Takagi T, Naito Y, Mizushima K etal. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig. Dis. Sci. 2010; 55: 2797-2804.
41. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 2002; 8: 240-246.
42. Berberat PO, A-Rahim YI, Yamashita K etal. Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm. Bowel Dis. 2005; 11: 350-359.